MerLion Pharmaceuticals
Frankfurt, Germany· Est. 2002
We are focused on the development of novel antibiotics to combat the evolving threat of bacterial infections in humans and animals.
Private Company
Funding information not available
About
We are focused on the development of novel antibiotics to combat the evolving threat of bacterial infections in humans and animals.
Small Molecules